Please login to the form below

Not currently logged in
Email:
Password:

Recordati

This page shows the latest Recordati news and features for those working in and with pharma, biotech and healthcare.

Grünenthal buys Zomig rights as AZ slimming drive continues

Grünenthal buys Zomig rights as AZ slimming drive continues

This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood

Latest news

More from news
Approximately 3 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    AstraZeneca, Takeda, Astellas Pharma, Novo Nordisk and Recordati take up the final five positions, though only two - Takeda (3.9%) and Astellas (9.3%) - recorded growth.

  • Deal Watch July 2016 Deal Watch July 2016

    BioD. $21.3 plus $56.5 contingent. $22m. 3.5x. N/A. Recordati. Pro Farma. ... Recordati has been busy on the acquisition front recently; in May the company acquired Italichimici for $145m, strengthening its gastroenterology and respiratory ranges, and

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    4. ). 63. Apricus Biosciences (formerly NexMed) / Recordati. Licence. Vitaros topical treatment for erectile dysfunction.

  • Deal Watch table for September 2013 Deal Watch table for September 2013

    246. Laboratorios Casen Fleet/ Recordati. Acquisition. Spanish pharmaceutical company. 123. Pacific Biosciences of California/Roche Diagnostics.

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    50. Opalia Pharma / Recordati . Acquisition of 90% stake. Branded generic drugs - dermatology, GI, respiratory.

More from intelligence
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Recordati promotes Andrea Recordati to COO Recordati promotes Andrea Recordati to COO

    Recordati promotes Andrea Recordati to COO. Move is part of a management reshuffle for the Italian pharma company. ... Milan-based pharmaceutical company Recordati has promoted Andrea Recordati (pictured right) to chief operating officer.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics